NCT02877277View on ClinicalTrials.gov

Epigenetics, Vitamin C and Abnormal Hematopoiesis - Pilot Study

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 8, 2016

Primary Completion Date

May 29, 2017

Study Completion Date

May 29, 2017

Conditions
Myelodysplastic SyndromeAcute Myeloid Leukemia
Interventions
DIETARY_SUPPLEMENT

Vitamin C

Oral intake of vitamin C tablet (500 mg) daily for 56 days

DIETARY_SUPPLEMENT

Placebo

Oral intake of placebo tablet daily for 56 days

Trial Locations (1)

2100

Rigshospitalet, København Ø

All Listed Sponsors
collaborator

Van Andel Research Institute

OTHER

lead

Rigshospitalet, Denmark

OTHER

NCT02877277 - Epigenetics, Vitamin C and Abnormal Hematopoiesis - Pilot Study | Biotech Hunter | Biotech Hunter